









Talal, A., McKay, I.J., Tanner, K.E., and Hughes, F.J. (2013) Effects of 
hydroxyapatite and PDGF concentrations on osteoblast growth in a 
nanohydroxyapatite-polylactic acid composite for guided tissue 





  Copyright © 2013 Springer 
 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
Content must not be changed in any way or reproduced in any 





























Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 1 
Effects of hydroxyapatite and PDGF concentrations on osteoblast 
growth in a nanohydroxyapatite-polylactic acid (nHA-PLA) 
composite for guided tissue regeneration 
 





* School of Engineering, University of Glasgow, Glasgow, G12 8QQ, UK. 
 
× Now at College of Dentistry, University of Dammam, Ad Dammam, Saudi Arabia.   
  
‡ Centre for Adult Oral Health, Barts and The London School of Medicine and Dentistry, Queen 
Mary University of London, Turner Street, LONDON E1 2AD, UK. 
 
+ Now at Dental Institute, Kings College London, Guys Hospital, LONDON SE1 9RT, UK. 
 2 
ABSTRACT 
The technique of guided tissue regeneration (GTR) has evolved over recent years in an attempt to 
achieve periodontal tissue regeneration by the use of a barrier membrane. However, there are 
significant limitations in the currently available membranes and overall outcomes may be limited. A 
degradable composite material was investigated as a potential GTR membrane material. Polylactic 
acid (PLA) and nano-hydroxyapatite (nHA) composite was analysed as a potential GTR membrane 
material. Its bioactive potential and suitability as carrier system for growth factors were assessed. 
The effect of nHA concentrations and the addition of platelet derived growth factor (PDGF) on 
osteoblast proliferation and differentiation was investigated. The bioactivity was dependent on the 
nHA concentration in the films, with more apatite deposited on films containing higher nHA content. 
Osteoblasts proliferated well on samples containing low nHA content and differentiated on films 
with higher nHA content. The composite films were able to deliver PDGF and cell proliferation 
increased on samples that were pre-absorbed with the growth factor. nHA-PLA composite films are 
able to deliver active PDGF. In addition the bioactivity and cell differentiation was higher on films 
containing more nHA. The use of a nHA-PLA composite material containing a high concentration of 
nHA may be a useful material for GTR membrane as it will not only act as a barrier, but may also be 
able to enhance bone regeneration by delivery of biologically active molecules. 
Keywords: Guided tissue regeneration, Polylactic acid, Nano-hydroxyapatite, Platelet Derived 
Growth Factor, Osteoblasts 
1. INTRODUCTION 
The two major objectives in the treatment of periodontal disease are firstly to arrest the progression 
of the disease and secondly to reverse the damage by regenerating lost periodontal tissues and 
supporting bone [1]. The technique of guided tissue regeneration (GTR) has evolved over recent 
years in an attempt to achieve periodontal repair [2]. The technique of GTR uses a membrane to 
cover the periodontal defect, which isolates the defect area from the overlying gingival soft tissue, 
thus allowing mesenchymal cells from the periodontal ligament and bone to populate the wound and 
stimulate periodontal tissue regeneration [3, 4]. A range of both resorbable and nonresorbable 
membrane materials have been used for GTR procedures. In general resorbable membranes are 
favoured as they do not require removal, as they gradually breakdown and are eliminated from the 
body by metabolic processes [5, 6]. However, there are significant limitations with the currently used 
membranes and overall outcomes of these procedures may be limited. Thus there is a need to 
develop new materials and production methods for resorbable membranes with appropriate 
mechanical properties to improve the clinical outcomes.  
Biodegradable polylactic acid (PLA) has been used in many biomedical applications due to its 
biocompatibility and resorbable properties. Since the early 1990s PLA has been used clinically in a 
range of applications including sutures, in drug delivery systems, as scaffolds and as fracture fixation 
devices [7, 8, 9]. PLA has also been investigated as a controlled delivery material for drugs and 
bioactive agents [10]. In this study we have investigated a nanohydroxyapatite polylactic acid (nHA-
PLA) composite material as a potential membrane material including its ability to release growth 
factors. 
The use of a ceramic such as HA or other calcium phosphates within degradable PLA may confer a 
number of potential therapeutic advantages on this material, including increased mechanical 
properties, promotion of cell attachment and osteoconduction and the potential for use as a vehicle 
for slow delivery of bioactive proteins such as growth factors. HA–PLA composite materials have 
been shown to be biocompatible, resorbable and have appropriate mechanical properties for bony 
applications [11, 12]. 
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Various studies have shown the potential of growth factors to enhance regeneration of periodontal 
tissues. Platelet Derived Growth Factors (PDGF), Bone Morphogenic Proteins (BMPs), Fibroblast 
Growth Factors (FGFs) and Insulin Like Growth Factors (IGFs) have all been shown to regulate 
osteogenic cells and may potentially enhance periodontal regeneration [13, 14, 15]. The 
incorporation of growth factor into a suitable GTR membrane may enhance significantly the 
outcome of GTR procedures. 
In previous studies we have shown that nHA-PLA composite materials can rapidly absorb proteins, 
which are subsequently released slowly over a number of days [16]. Protein release kinetics were 
shown to be dependent on both the nHA content and the manufacturing conditions of the material. 
The aims of this study were to investigate the proliferation and differentiation of osteoblast cells on 
nHA-PLA composites with different concentrations of nHA, to assess the potential of this material to 
act as a carrier system for growth factor delivery and to analyze the bioactivity of these nHA-PLA 
composites. In addition the nHA and the nHA-PLA composite films produced for the experiments 
were characterized by Scanning Electron Microscopy (SEM), Fourier Transform Infra Red 
spectroscopy (FTIR) and X-Ray Diffraction (XRD). 
2. MATERIALS AND METHODS 
2.1. Film fabrication 
PLA (PURAC Biochem, The Netherlands) with an L: DL ratio of 70/30 and nHA were used for the 
fabrication of nHA-PLA composite films. For the bioactivity study nHA with particle size less than 
200 nm was purchased from Sigma (UK). For the cell culture and PDGF studies nHA was 
synthesised, using an ethanol-based sol–gel method for the synthesis of nHA reported by Feng et al 
[17]. Calcium nitrate tetrahydrate [Ca(NO3)2.4H2O] (0.083M) and sodium hydrogen phosphate 
[(NH4)2HPO4] (0.05M) were mixed and the ratio of calcium and phosphate precursors were 
maintained at 1.66. Ca(NO3)2.4H2O was mixed in 50ml of ethanol and the solution was stirred and 
heated to 85°C, on reaching this temperature (NH4)2HPO4 which had been dissolved in 50 ml of 
water was added dropwise. Ammonium hydroxide (NH4OH) was added to the solution to maintain 
the pH above 10. The solution was stirred for 5-6 hrs as gel formation occurred (Equation 1). The 
final gel was then oven aged for 24 hrs at 40°C. 
10Ca(NO3)2 4H2O + 6(NH4)2HPO4 + 8NH4OH →  Ca10(PO4)6(OH)2 + 20NH4NO3 + 6H2O  
Equation: 1 
The aged sample was then heat treated, the temperature was increased at 10°C min-1 to 700°C and 
held for 1 hour at that temperature, the sample was cooled down to 20°C again at 10°C min-
1(Carbolite, Sheffield, UK). The powder was then ball milled for 12 hrs.  
To produce the PLA films 25 ml of chloroform was poured into spherical flasks and 0.5 g of PLA 
was added while stirring. The solution was then left on the stirrer for 24 hrs at room temperature. 
Then the solution was spread in 120mm Petri dishes and then left overnight to allow slow 
evaporation of the chloroform. For the production of nHA-PLA composite films nHA powder was 
added at the required concentration to give 10, 40 and 70 weight (wt) % to the PLA solution after 24 
hrs of stirring. These weight contents are equivalent to 4.2, 20.9 and 48.0 volume % using 1.25 
Mgm-3 and 3.156 Mgm-3 for the densities of PLA and HA respectively. These nHA-PLA solutions 
were then stirred for a further 48 hrs to achieve homogenous nHA dispersion, after which the 
solution was again spread on 120mm Petri dishes followed by slow evaporation of the chloroform. 
The same size of Petri dishes was used for all the films to obtain films with the same PLA content. 
After evaporation of the chloroform, the films were pealed off the dishes and were placed in a 
vacuum oven for one day. The films were then lightly annealed in the oven to relax any stresses 
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produced in the films during manufacture, by pressing the films between the bases of two Petri 
dishes in an oven at 70 ◦C for one hour. The films were then allowed to cool gradually overnight. 
This annealing prevented the films rolling up in the cell media during cell culture.  
The films were cut into 12 mm diameter samples and sterilized by ultraviolet (UV) irradiation. 
2.2. nHA powder and film characterization 
2.2.1 Fourier Transform Infra red spectroscopy (FTIR) 
FTIR spectra of the PLA and nHA-PLA composite films produced using synthesised nHA were 
collected using a Thermo-Electron Nicolet 8700 FTIR spectrometer. The spectra were obtained at 
8cm-1 resolution and a total of 256 scans were collected. 
2.2.2 Scanning Electron Microscope (SEM) 
The morphology and the size of synthesised nHA particles and the films were characterised by SEM 
(FEI Inspect F, EFI Company, The Netherlands) using the field emission technique. For nHA 
samples 20kV was used and for PLA and nHA-PLA composite films 5kV was used, to prevent 
damage to the PLA.  
2.2.3 X- ray diffraction (XRD) 
The nHA powder produced was characterized using XRD, to find chemical composition, crystal state 
and the crystalline content. A Siemens/Bruker D5000 Diffractometer, with monochromatic Cu Kα 
radiation (k = 0.15418 nm) was used to obtain the nHA powder XRD. Scans were obtained in the 2θ 
range = 20˚–60˚, with a step size of 0.02˚-1. Commercial nHA (Sigma, UK) was scanned to provide a 
comparative XRD pattern. 
2.3 Analysis of bioactive potential of films 
Bioactivity of films was analyzed by immersing 12mm diameter samples of PLA filled with 
commercial nHA in Simulated Body Fluid (SBF) which was prepared as described by Kokubo et al. 
[18]. 
Before soaking in SBF all samples were disinfected using 70% ethanol. Each disinfected sample was 
immersed in 20 ml SBF for 1, 7, 14, 21 or 28 days at 37°C. The SBF was changed after 14 days. At 
each time point, samples were removed from the solution and rinsed carefully with distilled water 
before drying in a vacuum oven at 40°C overnight. The samples were carbon coated and analyzed by 
SEM and energy dispersion spectroscopy (EDS) (FEI Inspect F, EFI Company, The Netherlands) 
2.4 Cell culture 
Primary rat calvarial osteoblasts isolated by collagenase digestion were used in the experiments. The 
cells were cultured and maintained in Minimal Essential Medium (MEM) Alpha medium (Invitrogen, 
UK) which was supplemented with 10% fetal calf serum (FCS) (Sigma Aldrich, UK), 0.3µg ml-1 
fungizone (Invitrogen) and 50µ ml-1 penicillin and 50µg ml-1 streptomycin (Invitrogen). The cells 
were grown in a humidified incubator at 37◦C with 5% CO2. The medium was replaced twice weekly. 
2.5 PDGF addition 
The effect of pre-adsorption of PDGF to the films on the proliferation of cells was evaluated. 100ng 
recombinant rat platelet-derived growth factor – BB (PDGF-BB) (Sigma Aldrich, UK) in 100 µl 
phosphate buffered saline (PBS) was added to the surface of the specimens placed in 24 well plates. 
The films were then incubated for three hrs at 37˚C. After this the PBS solution was carefully 
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removed from the surface of the films and cells were seeded 1×104 cells ml-1 on to the films. In a 
second set of films, rather than adding PDGF directly on the films, PDGF was added to the medium 
in solution. The concentration of PDGF in the medium was 100ng ml-1. 1ml of this PDGF containing 
medium was then added to each film placed in 24 well plates resulting in the addition of an equal 
total amount of PDGF in solution to that used for pre-adsorption treatments. Cells in medium 
without PDGF but with 1 or 10% FCS supplement were used as negative and positive controls 
respectively. The rationale for this method of soaking the samples in PDGF in phosphate buffered 
saline and then removing from the solution was that this models the expected clinical usage. The 
intention is that the dentist soaks the membrane in a PDGF solution at the chair side while preparing 
the operative site and then places the soaked membrane directly into the defect. 
2.6 Cell proliferation 
Cell proliferation on the films was assessed by an MTS assay. A solution of MTS (Promega UK Ltd, 
UK) and phenazine methosulfate (PMS) (Sigma Aldrich, UK) was used to determine the number of 
viable cells on the films. MTS changes colour on reacting with live cells. The amount of colour 
change, which is measured using a photospectrometer, is directly proportional to the metabolic 
activity of living cells. 
To evaluate cellular proliferation on different films, rat osteoblasts of 7-9th passage were seeded on 
PLA films and 10, 40, 70wt% nHA-PLA composite films. 90% confluent cells were trypsinized and 
cell density was adjusted to 3×104 cells ml-1. Sterile films were transferred into 24 well plates, a 
small dot of silicon was used to stick the films to the base of the wells. The films were seeded with 
3×104 cells ml-1 well-1 for 1, 2, 4, 7, 10 and 14 days in triplicates. Wells with no films, that is tissue 
culture plastic, were used as controls. For experiments in which PDGF was added, the cell density 
was decreased to 1×104 cells ml-1 well-1 and the medium was supplemented with 1% fetal calf serum 
instead of 10% fetal calf serum. The films containing cells were placed in a humidified incubator at 
37˚C with 5% CO2. Cell proliferation was analyzed at day three. 
2.7 Cell differentiation 
Cell differentiation was determined by measuring alkaline phosphatase (ALP) production by the 
osteoblast cells. 500µl p-nitrophenyl phosphate solution to the films in 24 well plates, the films were 
then incubated for at 37°C for one hour. Thereafter three 100µl samples were taken from each well 
and absorbance was measured at 405nm using a photospectrometer.  
SEM was used for morphological analysis of the cells on the films. At 14th day of incubation the 
films containing cells were washed with PBS twice before fixing the cells in 4% formaldehyde for 
15 minutes. The cells were then dehydrated by suspending in successive 50, 70, 80, 90 and 100% 
ethanol solutions for 5 minutes each. The films and cells were finally transferred to 
hexamethyldisilazane and were allowed to dry at room temperature. The films and cells were gold 
coated and analyzed under SEM (FEI Inspect F, EFI Ltd, The Netherlands) at 5kV. 
2.9 Data Analysis 
Statistical analyses of cell culture data were calculated by One-way ANOVA with Bonferroni’s post-
test with p < 0.05 was considered significant. Analysis was carried out using GraphPad Prism 
software. 
3. RESULTS 
3.1. Characterization of synthesized nHA 
Figure 1(a) shows the morphology and size of the nHA synthesized. The particles were agglomerates 
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of spherical nodules with the nodules being 40-60nm across and the agglomerates being 0.5-1.0mm 
across. XRD patterns of commercial and synthesized nHA are shown in Figure 1(b). Presence of a 
strong diffraction peak at 31.9° with other peaks at 26˚, 33˚ and 40˚ confirm the phase purity and 
high crystallinity of the material produced [19]. No non-nHA peaks were observed. The slightly 
increased width of the peaks for the synthesized nHA indicates lower crystallinity than for the 
commercial nHA. FTIR spectrum of the synthesized nHA powder is shown in Figure 1(c). The peaks 
at 3571 cm-1 and 631cm-1 represents OH groups. The peaks at 1040, 603 and 569 cm-1 represents the 
P-O absorption band. The CO3 group is represented by the peak at 1473 cm-1 [20]. 
  
 
Fig. 1 a SEM of nHA showing nodule size and morphology within the agglomerated granules (scale 
bar = 500 nm). b XRD patterns of commercial and synthesized nHA. c FTIR spectrum of 
synthesized nHA powder 
3.2. Characterization of films produced 
Figure 2(a) shows the morphology of 10, 40 and 70wt% nHA-PLA films, the imaged surface was the 
air surface during the casting process. The surface of 70wt%nHA-PLA films showed more nHA on 
the surface compared to 40 and 10wt% nHA-PLA films. The surface of 10wt%nHA-PLA film 
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appears smooth with the nHA well covered by PLA. Given that 10wt% nHA equates to 4.2 vol% 
nHA there seem to be good amounts of nHA visible on the surface. With 40wt%nHA again the nHA 
is well covered with PLA, whereas, the surface of 70wt%nHA-PLA film is rougher, irregular and 
shows micropores, here only some the nHA appears to be covered with PLA. Given that the nHA 
and PLA solution were mixed for 48 hours it can be seen that 48 vol% nHA leaves only 52 vol% 
PLA available to cover the high surface area nHA and that complete coverage has not been obtained. 
Figure 2(b) shows the comparative FTIR spectra of (a) PLA, (b) nHA, (c) 10wt%nHA-PLA film, (d) 
40wt%nHA-PLA film and (e) 70wt%nHA-PLA film. The spectra of 10wt%nHA-PLA, 40wt%nHA-
PLA and 70wt%nHA-PLA composites films show the characteristic peaks of both HA and PLA. As 
the concentration of nHA increased the intensities of PO4 peaks at 603 and 569 cm-1, which were 
attributed to phosphate from HA, increased relative to the intensities of PLA characteristic peaks at 
1760 (C=O), 870 (C-COO) and 756 (C=O) cm-1. 
 
 
Fig. 2 a SEM images of (i) 10 wt% nHA-PLA, (ii) 40 wt% nHA-PLA and (iii) 70 wt% nHA-PLA 
films (scale bars = 4 lm). b Comparative FTIR spectra of (a) PLA, (b) nHA, (c) 10 wt% nHA-PLA, 
(d) 40 wt% nHA-PLA and (e) 70 wt% nHA-PLA films3.3 Bioactivity of the films 
The SEM images (Figure 3) show PLA, 10wt%nHA-PLA, 40wt%nHA-PLA and 70wt% nHA-PLA 
films samples after immersion in SBF for 1, 14 and 28 days all at the same magnification. The 
amount of apatite formation increases with the increase in nHA content. On plain PLA films there 
was no apatite formation even after 28 days. On 10wt%nHA-PLA (Figure 3d-f) and 40wt%nHA-
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PLA (Figure 3g-i) no apatite layer was visible at day 1, however by day 14 apatite layers were 
forming and at 28 days the apatite layers covered more than 80% of the film surface. Maximum 
apatite formation was observed on films containing 70wt% nHA (Figure 3j-l) and even at day 1 there 
was an apatite layer formed on the film, by 28 days it fully covered the surface and appears much 
thicker than the apatite layer formed on other films. As the nHA content increased the size of the 
apatite nodules decreased indicating the growth of the apatite from more individual nucleation points. 
As the nHA concentration increases the number of potential nucleation points increases thereby 
allowing smaller apatite nodules to be formed. 
 
Fig. 3 SEM images of films after immersion in SBF (a)–(c) PLA, (d)–(f) 10 wt% nHAPLA, (g)–(i) 
40 wt% nHA-PLA, (j)–(l) 70 wt% nHA-PLA at (a), (d), (g) and(j) 1 day, (b), (e), (h) and (k) 14 days, 
and (c), (f), (i) and (l) 28 days (all scale bars = 5 µm) 
3.4. Cell proliferation on PLA films with 0, 10, 40 and 70 wt % nHA 
Osteoblast proliferation on the different films and the tissue culture plastic used as a control is 
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indicated in Figure 4(a) which shows the MTS signal which is related to cell metabolism. The cells 
showed highest metabolic rate on 10wt%nHA-PLA films and the cell metabolic rate decreased with 
the increasing nHA content in the films from 10% to 70%. The MTS signal reached a peak at 7 days, 
with no significant changes in the level between 7 and 14 days on the control surface, whereas lower 
peaks were seen at 10 days on the plain PLA with an intermediate level peak at 10 days on 
10%nHA-PLA. However for the 40% and 70%nHA-PLA the MTS signals were still increasing at 14 
days. 70wt%nHA-PLA films showed lower cell growth when compared to the other composite films, 
although all the composite films showed higher levels than the plain PLA film. The experiment was 
repeated five times and the results showed similar trends, although with different absolute values.  
Figure 4b shows the SEM images of cells at day 14 after culturing on plain PLA and the three 
different filled films. The cells are well spread and fully cover the surfaces. The cells on PLA and 
10wt%nHA-PLA films are densely packed and forming layers. On the films containing 40 and 
70wt% nHA the cells appear to be bridging over the surface depressions and pores formed by nHA 
particles. Furthermore on these films the cells are rounded and thus appear to still be dividing, 
compared to the flattened cells on the plain PLA and 10%nHA-PLA films. 
 
 
Fig. 4 a Osteoblast proliferation on tissue culture plastic (control), non-filled PLA and PLA filled 
with 10, 40 or 70 wt% nHA. Mean ± SD n = 3 per material and time. b SEM images of cells cultured 
to day 14 on (a) PLA, (b) 10 wt% nHA-PLA, (c) 40 wt% nHAPLA and (d) 70 wt% nHA-PLA films 
(all scale bars = 2 µm) 
3.5. Cell proliferation on PLA films with 0, 10, 40 and 70 wt % nHA in response to PDGF 
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Figure 5 shows the metabolic activity of cells at day 3 on films loaded with PDGF and on films in 
which PDGF was added in the cell medium. Two controls were used for each film type, culture 
medium with 1% or 10% FCS but no PDGF. The films on which PDGF was pre-adsorbed showed 
higher cell metabolic activity when compared to cultures where PDGF was added to the cell medium 
in solution. There was no difference between cell metabolic activity on positive control films with 
10% FCS and films with PDGF in the medium, whereas PDGF adsorbed to films caused increased 
metabolic activity. The lowest cell metabolic activity was seen on negative control films with 1% 
FCS and no PDGF added. The experiment was repeated five times and the results showed similar 
trends although with different absolute values as would be expected with cell culture studies. 
 
Fig. 5 Osteoblast cell proliferation at day 3 in response to PDGF adsorbed to films or in solution in 
the medium. 1 and 10 % serum in the medium were used as negative and positive controls, 
respectively. Mean ± SD n = 3 per material and serum condition. *Significantly less than other 
groups. **Significantly greater than other groups, P<0.05 one-way ANOVA and Bonferroni post-test 
3.6. Alkaline phosphate activity 
Figure 6 shows alkaline phosphatase activity of the cells after 14 days culture on various films. The 
data was normalized for cell number using the MTS assay as measure of cell number. The cells on 
70wt% nHA-PLA films showed a significantly significant  increase in alkaline activity which 
indicates cell differentiation, compared to control and 10wt%nHA-PLA films with a non significant 
increase for 40%nHA-PLA. 
 
Fig. 6 ALP activity of osteoblasts cells seeded on different films for 14 days (n = 3). Mean ± SD. 
*Significantly greater than other groups, P<0.05 one-way ANOVA and Bonferroni post-test 
4. DISCUSSION 
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A range of materials are currently used as barrier membranes for guided tissue regeneration (GTR), 
with various advantages and disadvantages. There is considerable interest in further developments of 
regenerative techniques to improve outcome and predictability. One potential development is using a 
composite combining the properties of different materials to enhance the treatment outcome. 
Furthermore, growth factors can be incorporated into the membranes to encourage their local release 
to enhance regeneration. 
In this study nHA-PLA composite films have been analyzed as potential materials for GTR 
membranes. The aim was to develop a membrane which can enhance regeneration by combining the 
properties of resorbable PLA and bioactive nHA. Furthermore, it was designed to also have the 
ability to deliver bioactive proteins such as growth factors at the defect site, thus further enhancing 
regeneration. Hydroxyapatite is a known biocompatible and osteoconductive material and has the 
ability to absorb and release proteins [21]. nHA with particle size between 40-60 nm was 
successfully produced and SEM (Figure 1) of nHA shows the nanospherical structure of the particles. 
Nanospherical structured HA is advantageous as it provides greater surface area for cell attachment 
and more binding sites for protein absorption. The crystallinity and purity of nHA was confirmed by 
XRD which only showed the peaks associated with HA and no peaks related to tricalcium phosphate 
or calcium oxide were present. Similarly, the FTIR spectra showed typical HA characteristics [22]. 
SEM images of films with different nHA content show that as the nHA content increases the surface 
of film becomes rougher, which again could provide increased surface area for cell attachment [23]. 
In addition generally an increase in filler content in a composite increases the modulus [24, 25]. 
However, the proposed application of these films is to form the bone contacting surface of a fibre 
reinforced GTR membrane and the main purpose of the film is to stimulate bone and periodontal 
ligament regrowth. 
In FTIR spectra of films there was no shift of PLA carbonyl peak at 1760cm-1 showing that the 
mixing of PLA and nHA is purely physical and no chemical bonding has taken place. Phosphate 
bending peaks of HA at 569cm-1 and 603cm-1 and their height compared to PLA peaks increase as the 
nHA content increases from 10 to 70 %. 
Bioactive materials, as indicated by the formation of an apatite layer on the implant surface during 
soaking in SBF [26], favour the growth of osteoblasts. The apatite which is formed on the surface of 
the bioactive material is carbonate-containing hydroxyapatite with small crystallites and resembles 
bone mineral in composition and structure. The formation of apatite layer was seen to be 
proportional to the concentration of nHA in the films, with faster apatite formation on films 
containing higher nHA concentrations. It has been proposed that osteoblasts preferentially proliferate 
and differentiate on the apatite layer and produce apatite and collagen [27]. The apatite layer was 
formed on day 1 on films containing 70 wt% nHA, whereas it did not appear on the plain PLA films 
even at 28 days. Furthermore, the morphology of the apatite layer formed on the films containing 40 
and 70 wt%  nHA was different from the layer formed on 10wt%nHA-PLA films. The layer formed 
on 40 and 70 wt% nHA-PLA films showed a finer structure and a more continuous apatite layer, 
whereas the apatite layer formed on PLA and 10 wt% nHA-PLA film presented a more globular 
appearance. This difference may be due to presence of more nucleation sites for apatite formation in 
films containing increased amounts of nHA. 
We tested the effect of nHA content on the proliferation and differentiation of osteoblasts. Both cell 
proliferation and differentiation were assessed on the same samples so the results can be correlated. 
Initial cell adhesion to a material is important because it controls the subsequent processes of cell 
proliferation and differentiation [28, 29]. Osteoblasts showed higher proliferation, as assessed by 
MTS activity, on films with lower nHA content and lower proliferation on films with higher nHA 
content. There was minimal difference between the number of cells on PLA and 10wt%nHA-PLA 
films at day 10 and 14. However, this may be because the cells had already reached confluence at 
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day 10, whereas the cells on 40 and 70wt%nHA-PLA films were still proliferating at day 10, 
showing an increase in number between days 10 and 14. 
ALP activity can be attributed to the degree of cell differentiation [30]. In general there is a 
reciprocal relationship between cell proliferation and differentiation in cell culture and as cells start 
to differentiate, they cease proliferating. In our study increased ALP expression, showing 
differentiation of cells on films with high nHA content may explain the low number of cells on 
40wt%nHA-PLA and 70wt%nHA-PLA film, and the higher number of cells on PLA and 
10wt%nHA-PLA films. The highest ALP activity was seen in the cells on 70wt%nHA-PLA films, 
which is probably due to the differentiation effect of nHA on these cells. Low levels of ALP in cells 
on PLA and 10wt%nHA films suggest limited differentiation of these cells. So we speculate that 
with no or low nHA content the cells continually proliferate, whereas with higher nHA content the 
cells slow growth in order to differentiate. This theory is in agreement with classical osteogenesis 
timelines and behaviours as shown by Stein and Lian [31]. Our results are also in support of various 
studies that the presence of HA can cause bone cells to differentiate and even to start to deposit 
mineral [32, 33, 34]. The presence of the HA should have a further advantage, PLA degradation 
products are acidic and therefore have been known to cause an adverse biological response. However, 
the addition of HA or tricalcium phosphate, which are chemically basic, has been shown to limit 
changes in the pH [12]. 
PDGF is a heparin-binding polypeptide and has mitogenic, proliferative and chemotactic affect on 
connective tissue cells [36]. PDGF adsorption into the composite films and its subsequent effect on 
the proliferation of cells was analyzed. The cells which were treated with PDGF, either by adding 
PDGF in the serum or by absorption into the films, showed increased proliferation on day 3 as 
compared to 1% serum negative control samples (Figure 5). Cell proliferation on samples where 
soluble PDGF was added to the medium and on control samples containing 10% serum in the 
medium were similar. However the highest cell proliferation was seen on films where PDGF was 
pre-adsorbed to the films. This result shows that the effect of PDGF on the cells was highest where a 
carrier was used and also establishes that these films can be used as a carrier for growth factor 
delivery. The absorption of the PGDF into the HA particles increases the cellular response to the 
particles. The HA content can be optimized in terms of balancing osteoblast proliferation and 
differentiation. 
5. CONCLUSIONS 
All nHA-PLA composite films showed the formation of an apatite layer, however the fastest apatite 
layer formation was on 70wt%nHA-PLA films. A composite material containing high concentration 
of nHA may be a very useful material for application as a GTR membrane. Highest proliferation of 
osteoblasts was achieved on 10wt%nHA-PLA films, whereas highest ALP activity, thus 
differentiation, was shown by cells cultured on films containing 70wt%nHA. PDGF was shown to 
enhance the proliferation of cells, more proliferation was shown by cells on films loaded with PDGF 
which shows the suitability of these composite as a carrier system for growth factor delivery. 
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